Arcus Biosciences price target lowered to $35 from $40 at Morgan Stanley
PremiumThe FlyArcus Biosciences price target lowered to $35 from $40 at Morgan Stanley
16d ago
Merck price target raised to $134 from $132 at Morgan Stanley
PremiumThe Fly
Merck price target raised to $134 from $132 at Morgan Stanley
16d ago
Elanco Completes Sale of Aqua Business
PremiumPress Releases
Elanco Completes Sale of Aqua Business
18d ago
Merck, Orion mutually exercise option for exclusive rights to opevesostat
PremiumThe FlyMerck, Orion mutually exercise option for exclusive rights to opevesostat
26d ago
Orion, Merck announce exercise of options providing Merck rights to opevesostat
PremiumThe Fly
Orion, Merck announce exercise of options providing Merck rights to opevesostat
26d ago
Merck announces positive EU CHMP opinion for WINREVAIR
PremiumThe Fly
Merck announces positive EU CHMP opinion for WINREVAIR
29d ago
Esperion downgraded to Underperform from Neutral at BofA
PremiumThe FlyEsperion downgraded to Underperform from Neutral at BofA
1M ago
Merck treatment of gastric cancer granted FDA orphan designation
PremiumThe Fly
Merck treatment of gastric cancer granted FDA orphan designation
1M ago
Ligand collaborator Merck receives FDA approval for CAPVAXIVE
PremiumThe Fly
Ligand collaborator Merck receives FDA approval for CAPVAXIVE
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100